You Wanna Sue Your Employer for Overtime? The Labor Department Has an App for That!
Client Alert | 1 min read | 05.17.11
On May 9, 2011, the U.S. Department of Labor (DOL) announced a free smartphone application designed to help employees independently track hours worked. In what is apparently a regulatory "first," the app is being co-marketed with Apple and available on iTunes The app allows users to enter hours worked either manually or automatically using a timer, and to both view and e-mail reports of time worked. The app also includes a prominent "contact us" button, with links that allow users to easily call or send an e-mail to the DOL's Wage & Hour Division. The app only permits recordation of basic overtime calculations, and does not handle items such as tips, commissions, bonuses, deductions, holiday pay, or shift differentials. Nothing in the app requires correlation of information recorded against the employer's timekeeping system.
In addition to providing valuable information for a Wage Hour division investigation, the app gives employees (and plaintiffs' lawyers) the ability to create contemporaneous records of time worked. In cases where employer time records are alleged to be incomplete, such records can give plaintiffs a significant boost in proving damages, particularly in collective and class actions. As lower courts continue to struggle over the proper interpretation of the Supreme Court's 1946 decision in Anderson v. Mt. Clemens Property, the accuracy of employee recollections of hours worked has become an increasingly important issue in litigating these cases. For employers, this initiative reinforces the importance of making sure accurate timekeeping records are maintained for all non-exempt employees.
Contacts
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief

